On-Site Workshop

Depending on your company's situation, one complimentary workshop may be offered.  Most commonly workshops are requested to:

(A)  discuss an orphan licensing or acquisition strategy in one or more therapeutic areas

(B)  explore options for company exit or out-licensing, including academic out-licensing

(C)  thoroughly evaluate the merits of a pipeline asset (internal or external) in-licensing or acquisition

---

BD Strategy

• Overall assessment of BD strategy within the orphan space
• Discussion of prioritization methods and opportunity identification

Pipeline Assets

• Evalution of assets based on epidemiology and expected pricing & reimbursement
• Discussion of Global opportunity and forecast based on integrated inputs and analogs

Disease Deep-Dive

• Presentation of opportunity with a disease
• Integration of literature, KOL research, data
• Genetic sub-typing or other important patient identification methods
• Patient forecasting finalization based on disease trends and emerging therapies